Clinical Development

Signant Health has partnered with the software company o connect its platforms for the management of clinical supply chain inventory, labels, and content.

A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.

The two companies are collaborating to generate subject data sets designed to help users find insights that can speed up research and improve patient care.

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

The CRO and DTx specialist are joining forces to conduct a hybrid clinical trial of a potential digital therapeutic that is aimed at treating fibromyalgia.

A joint study conducted by analysts from Medable and the Center for the Study of Drug Development points toward shorter cycle times, cost savings, and […]

During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

This monthâs announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

The biotechnology company has reported its candidate for treating amyotrophic lateral sclerosis patients has shown promising results in an early-phase study.

A pediatric clinical trial expert from the CRO discusses the unique challenges involved in designing a study when the patients involved are little ones.

Taking place July 20, the Decentralized Trial Technology webinar will share insights and experiences from a group of knowledgeable virtual trial experts.

In this second of a two-part series, a leader from the CRO discusses the types of technologies supporting DCTs and what might lie on the […]

The latest indepth report from the AI-centric analytics provider reveals nearly half of US cancer clinical studies enroll no Latino patient participants.

In this first of a two-part series, an expert discusses various factors behind the DCT formatâs rapid rise and likely longevity in the drug development […]

England’s cost-effectiveness watchdog has recommended Eli Lillyâs Verzenios treatment as an option for adjuvant treatment of certain forms of breast cancer.

On July 20, a collection of noted industry experts will lead a lively discussion on the rapid evolution of DCTs, and what advances might be […]

Electronic health record solutions provider Athenahealth has partnered with Withings Health Solutions to put the RPM tech into place for clinical and care use.

The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.

An expert from the decentralized trial solutions company shares how eCOA and ePRO can be useful tools that improve the collection and quality of such […]

The pharmaceutical company has enlisted the help of the AI and NLP tech specialist to streamline clinical study report generation and submission processes.

The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.

uMotif and ClinOne announced at the 2022 DIA Global Annual Meeting that they have partnered to deliver an integrated solution for eCOA and eConsent in […]

This monthâs announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

The newly launched CDMO plans to set up two new manufacturing lines, after expanding into a 5,000-square-meter manufacturing facility.

The patient recruitment solutions company plans to work with the charity to support research and clinical trials through a range of fundraising activities.

An expert from the trial tech company discusses tools that can prove useful for trial teams looking to avoid employee shortages plaguing other industries.

Offering 13 topic tracks to choose from, the DIA Global Annual Meeting (scheduled June 19-23) lets attendees chose the path that fits their unique interests.

The June 20 Medical Heroes Appreciation 5k Run and Walk, scheduled during the DIA Global Annual Meeting in Chicago, salutes contributions of trial volunteers.

During the upcoming BIO International Convention, experts from CerFlux, the MD Anderson Cancer Center, and Aga Khan University will weigh in with insights.

Former Medable vice president Brian Ongioni has joined the trial tech provider as vice president of product, continuing a quest for patient-focused solutions.

The division of Johnson and Johnson has selected the health tech company to create a mobile app to be used to collect data in a […]

Withings Health Solutions’ new remote patient monitoring (RPM) system seeks to tackle complexities identified after the launch of its first offering in the space.

Northway Biotech, a contract development and manufacturing organization (CDMO) based out of Vilnius, Lithuania, is set to open a facility in Boston, US.

The digital medicine solutions developer has received $300m in a Series D investment round, which will be used to help scale up its virtual care […]

The virtual research organization has developed digital instruments designed for assessing stools and recording crying episodes in pediatric clinical studies.

This monthâs announcements on new technology, awards, partnerships, and more include eClinical Solutions, COTA, Greenphire, and other notable companies.

Experts and organizations are honoring the occasion (designed to celebrate research accomplishments and achievements) with insights, education, and more.

A leader from the neurobiomarker platform provider tells how use of ML and other advanced analytical tools can help make better use of complex information.

The pharmaceutical company is partnering with Yseop to install the software companyâs Augmented Analyst, designed to elevate and accelerate data analysis.

The agency has removed the hold placed on the pharmaceutical companyâs IND for injectable lenacapavir, which is intended for HIV treatment and prevention.

The cloud software company provided the pharmaceutical company with the newly introduced clinical trial management system to help streamline its processes.

The companyâs analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.

The cancer trial-matching company is partnering with MPN Research Foundation to help match patients with a group of rare blood cancers to clinical trials.

A leader from the clinical technology company discusses some of the pain points in data collection and analysis, and tools that can help users level […]

ObvioHealth and 1nHealth have joined to launch an initiative aimed at helping clinical trials avoid being shut down by smoothing the change to decentralized.

Newly launched life sciences company Sionna Therapeutics has secured funding to fuel discovery and development of drug candidates to treat cystic fibrosis.

The decentralized clinical trial specialist has acquired CureClick to add to its offerings a platform intended to expand awareness of study participation.

The latest news on expansions, innovations, awards, and more includes items from Eversana, DHL Supply Chain, X-Chem, Medidata, and other notable companies.

An expert from the health tech company explains how AI, natural language processing, and other tools can improve pharmaceutical product safety reporting.

The two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices.

The companyâs recent purchase by Drug Safety and Pharmacovigilance Services Solutions reportedly will fuel expansion of its Reportum PV platform technology.

An expert from trial tech specialist Komodo Health talks about how real-world evidence use could elevate study design, conserve costs, and improve recruitment.

A recent online event hosted by the patient services company invited a number of women to share their experience and insights working in the research […]

The partnership among three research and data specialists is aimed at creating a global database to support faster development of novel cancer treatments.

Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.

Experts from the Decentralized Trials and Research Alliance and Rafael Pharmaceuticals discuss progress and possibilities during Clinical Development Advances.

An expert from the clinical technology solutions provider discusses some of the top challenges associated with technology adoption, and how to tackle them.

The companies plan to work on developing personalized care solutions via digital pathology to come up with treatment options for patients with solid tumors.

A new study will seek to understand the bodyâs response to the Nipah virus in order to support development of vaccines.

DCT company ObvioHealth helped digital therapeutic firm Renovia evaluate a way of helping women with incontinence issues strengthen pelvic floor muscles.

The companyâs analysis of clinical research activity in the region shows the conflict will have long-lasting effects that reach beyond the countryâs borders.

The medication adherence specialist is joining IT4Anxiety, a project focused on dealing with anxiety in patients with mental disorders, via technology.

While strides have been made recruiting more representative patient populations, more can and should be done, according to an Oracle Health Sciences leader.

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

During Outsourcing-Pharmaâs March 23 webinar, Clinical Development Advances, leaders from different areas will share innovative technology and practices.

During Outsourcing-Pharmaâs March 23 webinar, Clinical Development Advances, leaders from different areas will share innovative technology and practices.

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

A leader from the VCRO shares how far the industry has come with decentralized adoption, where opportunities for improvement exist, and what lies ahead.

Changing to DCT is more than merely flipping a switch; two leaders from the Thermo Fisher Scientific division offer advice for implementing the format.

A leader from the CRO talks about the unique considerations that cancer studies have at every stage, and how technological solutions can help address them.

The pharma firm has allied with the biotech to create a scalable data, analytics, and infrastructure platform to generate insights from healthcare biobanks.

The two companies, along with Datavant, will combine real-world data and decentralized platforms to yield better patient information management and insights.

Experts from the clinical tech firm talk data challenges and how monitoring technology can enable sites and sponsors to better manage audit trail reviews.

Medable has added Cognizant to its Medable Partner Network, designed to help companies launch their clinical trials more quickly and run them more efficiently.

The company (which specializes in developing therapies for rare cancers) currently is working on a number of candidates, including its lead drug CPI-613.

The recent Outsourcing-Pharma webinar hosted a trio of industry experts highlighting challenges, opportunities, and innovations in the rare disease realm.

With a specific focus on clinical trials involving treatments for rare diseases, Orphan Reach seeks to build upon the services that conventional CROs offer.

The two companies, which have been collaborating for 15 years, reportedly will focus on elevating decentralized trial solutions to develop new therapies.

Created via a joint effort with EY, the pharmaceutical company launched ASPIREs, a program intended to improve its clinical trial processes in numerous areas.

In its forward-looking report on digital health, the consulting outfit offers predictions on what changes are ahead and how they might impact the field.

This monthâs list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

According to a representative from the decentralized trial solutions company, the field of digital therapeutics is poised to gain significant popularity.

An expert from the institutional review board services company advises what trends to look for in the clinical trial industry over the course of coming […]

In this second of a two-part series, experts from the clinical research organization share thoughts on how data management technology, personnel, and partnerships have evolved.

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

In the first of a two-part series, leaders from the CRO discuss how study data has progressed in recent years and how trial teams can […]

Vision, part of the companyâs Clinical Maestro platform of software-as-a-solution applications, enables study teams to manage clinical vendor oversight.

An expert from the CRO discusses the role real-world data plays in developing therapies, with benefits ranging from speeding recruitment to decreasing costs.

The collaboration between the trial tech company and heathcare firm is aimed at increasing study access at MinuteClinic locations using Medableâs software.

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

The pharma firm has announced the agency has approved the companyâs investigational new drug application for its Phase II trial of pemvidutide for obesity.

In a partnership with Medable, a center at the university discovered costs linked to investing in decentralized studies far outweigh the eventual benefits.

A leader from the RBQM solutions specialists offers a preview of his SCOPE 2022 presentation on tools suited to decentralized trial design and management.

The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.

Am expert from the CRO discusses unique challenges associated with running clinical trials that stretch across national boarders and how to conquer them.

The agency has given the go-ahead on an IND application for a study evaluating Ananda Scientificâs Nantheia ATL5, a candidate for treating opioid use disorder.

Regulatory bodies in the European Union have launched an initiative to develop the region as a focal point for clinical research and to better integrate […]

Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.

With the amount of available data increasing and technology evolving, says a company leader, the job of data manager is more demanding than ever before.

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.

The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern Universityâs Shirley Ryan AbilityLab.

Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

A leader from Oracle Health Sciences shares insights on how drug development and research pros collaborated to overcome formidable challenges this year.

According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.

The company has released a survey of cancer doctors; 83% of those polled believe real-world data is crucial to accelerating cancer research and treatment.

While the pandemic saw many trials to shift to decentralized midstream, an expert from the trial tech firm suggests a ground-up design approach is preferable.

A leader from the Decentralized Trials and Research Alliance offers perspective on the tools, technology, and thinking needed to advance clinical research.

The Parkinsonâs Progression Markers Initiative, built using Evidation Healthâs research platform, aims to triple enrollment and recruit online participants.

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.

The pharma firm has gifted $1m USD to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing […]

A leader from the advanced data and artificial intelligence specialist suggests ways to advance data collection through new tools, techniques, and thinking.

Sited in Pennsylvania, the excipients specialistâs new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

A survey on perceptions toward the decentralized clinical trial format, conducted by Climedo, shows the industry is aware of the benefits but faces barriers

An expert from the ]contract research organization discusses the impact virtual trials have had on the industry, and how that transformation is likely to continue.

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.

A leader from the pharmacovigilance solutions firm discusses the ins and outs managing safety documentation and offers advice on how to deal with them.

Leaders from the trial tech provider discuss how human-focused technology on eClinical platforms can tackle inefficiencies associated with traditional studies.

The alliance is aimed at expanding service to pharmaceutical firms and other partners, and advancing treatment options for patients across North America.

According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next […]

According to the pharma firm, Saphnelo (anifromulab) combined with standard therapy resulted in reduction of systemic lupus erythematosus disease activity.

CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem […]

The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

The decentralized tech specialist has acquired Digital Artefacts, a research tech firm focused on cognitive, behavioral, and physiological data capture.

The group is collaborating with AbbVie, Janssen, Novartis, Pfizer, and UCB to help advance nocturnal scratch as a digital endpoint for atopic dermatitis.

The trial will evaluate a weekly regimen of islatravir and lnecapavir in HIV patients who are virologically suppressed while on antiretroviral therapies.

The cloud software firmâs Digital Clinical Trials Survey Report reveals that the industry is adapting to challenges caused by COVID-19 and other factors.

An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.

The respiratory care specialist shares perspective on issues faced by respiratory studies, and how to overcome such obstacles to get therapies to market.

Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.

The University of California at Irvine and the data firm will work on solutions that help integrate health data for both clinical trials and patient […]

A leader from the pharmaceutical firm talks about some of the most impactful technologies and shares a number of notable advancements made by the company.

According to two leaders from the healthcare tech firm, improving the way healthcare data is collected, stored, and used can contribute to improved care.

The patient-centric platform firm is gathering representatives from different corners of the industry to work on solutions to drive progress and innovation.

A representative from the school explains how tools like artificial intelligence and natural language processing can help elevate personalized medicine.

An expert from the CRO explains the evolution of data technologies put to use in clinical studies and offers advice on how to best make […]

According to the CEO of patient recruitment specialist SubjectWell, keeping up with the specialized needs of virtual studies calls for innovative thinking.

Leaders from ArisGlobal and Eversana explain the benefits of carefully selecting a research partner with a robust set of capabilities to see a project through.

A leader from Swift Medical describes the companyâs skin and wound management technology, and how their tech empowers patient capture of vital information.

Conducted by patient services specialist Greenphire, the survey checks in with contract research organizations and shows how they are approaching obstacles.

A leader from Firma Clinical Research advises that while using RWD can be daunting, putting the data to use can lead to a number of […]

The technology is designed to enable connection to any source data system, enabling connectivity in identifying, monitoring, and managing trial risks.

The technology is designed to enable connection to any source data system, enabling connectivity in identifying, monitoring, and managing trial risks.

The cancer-centric pharma firm will work with the Houston-based cancer center to pinpoint new indications and biomarkers for its drug candidate, seclidemstat.

According to a leader from the health engagement solutions firm, intelligent use of technology tools can add patient-centricity and realism to a study.

Swift Skin and Wound is a digital imaging technology designed to support decentralized clinical trials conducted to evaluate skin and wound treatments.

Stakeholders in the Rare Disease Cures Accelerator-Data and Analytics Platform initiative are partnering in hopes of bringing treatments to patients faster.

A physician assistant from Hawthorne Effect shares how she and other trained health professionals contribute their knowledge and talents to in-home studies.

The digital therapeutics firm’s Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimerâs.

According to an Oracle Health Sciences leader, companies looking to take on decentralized trials should keep a few things in mind before taking the plunge.

A survey on remote patient monitoring, conducted by health solutions firm Vivalink, anticipates notable growth in virtual studies during the next year

The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option.

The trial tech firm says analysis of trials in low- and middle-income regions reveals that innovative statistical methods could make a huge difference.

The decentralized trial tech firm will work with Applied VR on five studies testing the viability of virtual-reality therapy in treating pain patients.

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

Merck (known as MSD outside the US and Canada) will partner with the data insights firm on solutions that progress real-world research and innovations.

A study conducted by trial tech firms Curedatis and Climedo Health reveals what trial professionals view as challenges and opportunities in digitalization.

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.

An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.

A leader from Veeva Systems shares perspective on what factors are impacting clinical trial data management, and how the industry can adapt to the changes.

This monthâs roundup of equipment, decentralized technology, partnerships and other items includes news from Medidata, PerkinElmer, Syneos and other firms.

The National Institute on Aging has launched Outreach Pro, an online tool aimed to help connect with underrepresented populations for Alzheimerâs trials.

The Heart of Athletes study, using Deloitteâs ConvergeHealth MyPath for Clinical platform, aims to examine heart inflammation in athletes with the virus.

The pharma firm is working with five US colleges and universities onto create programming designed to boost recruitment of Black talent in the industry

A leader from Tools4Patient discusses the importance understanding ties between the two in reducing the impact of the placebo response in clinical trials.

A leader from the clinical research tech specialist explains how the use of AI is increasing in the field and outlines the many ways it […]

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

The drug, intended for adult patients with moderate-to-severe systemic lupus erythematosus, is the only new therapy approved for SLE in more than a decade.

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.

A recent check-in with several biopharma and CRO companies, conducted by Life Science Strategy Group, indicates adjustment to pandemic-related challenges.

The two pharma firms will partner to study the efficacy of Opdivo, paired with a SHP2 inhibitor, to treat non-small cell lung cancer with KRAS […]

The health data specialist and pharma firm are partnering on solutions around remote collection of digital data for detection and monitoring of treatments.

A leader from the artificial intelligence solutions firm discusses how advanced analytical tools can help researchers make the most of mountains of data.

A recent survey conducted by dosing technology firm found that the vast majority (85%) of patients think that personalized medicine stands to improve care.

The World Health Organization hopes to encourage the development of novel therapies for tuberculosis by spotlighting key clinical study characteristics.

The oncology-centered analytics firm will work with the DC-area healthcare provider to delve into discovery and development of novel cancer treatments.

Eli Lilly and Company and Banner Alzheimerâs Institute have announced a strategic research collaboration as part of the planned Phase 3 study for donanemab in […]

A representative from the medication management solutions company suggests patient behavior data can be used to improve adherence to trial drug regimens.

A leader from the clinical tech consultancy shares advice on how to employ training to help keep up with the rapidly evolving field of data […]

The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.

According to a leader from CRO Quanticate, the research industryâs increased use of real-world data is leading to a broad range of benefits in trial […]

A leader from life-sciences IT consultancy Daelight Solutions shares how the clinical trial data landscape has changed and offers advice on how to keep up.

Antibody responses against the SARS-CoV-2 spike protein were found in 99% of volunteers after the second dose of ReiTheraâs COVID-19 vaccine candidate, according to Phase […]

During the Rare/Orphan Diseases, Special Patient Population webinar, a group of industry experts discussed challenges and opportunities faced in the field.

A leader from IQVIA suggests what to look for when seeking ways to automate drug safety processes, while maintaining security and customer satisfaction.

The immunotherapy firm is conducting a Phase III trial centered on an innovative approach to treating recurrent glioblastoma, an aggressive brain cancer.

The two entities will work together to evaluate digital sensors and other tools used in clinical research, checking the items for accuracy and equity.

Thanks in part to the recent completion of an $8m investment, 2020 On-site plans to expand its services, including the mobile support of vision research.

The companyâs Ryze technology combines a clinical MDR and study automation platform, designed to accelerate and optimize design and execution of trials.

The survey, conducted by Ai-powered study matching company TrialJectory, indicates more patients than ever are interested in clinical trial participation post-pandemic.

The pharmaceutical company reports favorable results in a recent study exploring mobocertinib in treating certain non-small cell lung cancer patients.

Medable will collaborate with Aural Analytics in an initiative funded by the NIHâs seven-year Beau Biden Cancer Moonshot research and development program.

Elligo Health Research is joining forces with Laguna Clinical research Associates to expand access to clinical care to a broader range of patient populations.

These organizations hope to connect with attendees at the event, sharing clinical research ideas and innovations in sessions and the virtual exhibit hall.

Thanks in part to swift COVID-19 response and relatively low infection rates, more sites and sponsors are looking at the region to locate their studies.

A leader from the virtual research solutions specialist discusses how a greater pushed toward home-based research can lead to a range of benefits.

The US Food and Drug Administration (FDA) has approved Biogenâs Aduhelm (aducanumab) for the treatment of Alzheimerâs: making it the first new treatment approved for […]

The Digital Health Measurement Collaborative Community is bringing together stakeholders to improve approaches and technologies in research and healthcare.

The life-sciences data outfit has chosen former FDA principal deputy commissioner Amy Abernethy to serve as president of its clinical research business.

The University of Kansas Cancer Center has joined with trial tech provider Complion to develop a shared investigator platform for use in a range of […]

The pharma firm plans to use the StudyTeam platform to accelerate development, ease site burdens and improve patient matching for breast cancer studies.

A robust research and innovation ecosystem makes Italy an attractive life sciences hotspot, according to a post from an Italian trade delegation at Bio Digital […]

With the Engagement Solution Center, the patient-recruitment services specialist is aiming to improve the patient-centricity and inclusivity of studies.

According to a leader from the pharma firm, considering a patientâs needs and seeing them as a whole person is vital to successful studies and […]

The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.

A representative from the digital experience management firm discusses how improving the quality of tech interactions with patients can elevate results.

An executive from the virtual research organization discusses the importance of advaincing studies through innovation and a patient-centric approach.

The UK-based development and research firm hopes to accelerate patient access to psychedelic therapies for treatment of various mental health conditions.

A leader from oncology trial insights and analysis specialist Inteliquet discusses how cancer studies can recover after the impact of the global pandemic.

The trial technology provider and contract research organization will collaborate on tech and process solutions designed to accelerate clinical studies.

In this second part of a series on the state of clinical research, a leader from Javara lays out ideas to bring clinical research and […]

A leader from the clinical development services provider recommends using industry modal values to avoid protocol amendments, enrollment problems and more.

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one […]

In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and […]

In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and […]

Preclinical research, published in Nature, suggests a new avenue for Alzheimerâs disease (AD) treatment, through restoring lymphatic flow in the brain

The companyâs new chief scientific officer, a 30-year industry veteran, shares her informed thoughts on the future direction of the research field.

Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.

The 6th annual Clinical Research as a Care Option conference, taking place April 26-27, brings together experts seeking solutions to elevate the industry.

An advanced cancer detection platform from C2i Genomics (reportedly capable of spotting miniscule traces of the disease) recently landed $100m in funding.

Two leaders from World Courier and Lash Group talk about how bringing trial supplies and services right to patients can boost recruitment and retention.

A leader from the laboratory solutions provider talks about how the virus has created challenges for researchers, and how those obstacles might be cleared.

Artelo Biosciences is investigating the viability of its novel cannabinoid product as a solution to treat cancer-related anorexia in oncology patients.

The two technology companies plan to work together to provide a unified platform that serves to streamline workflow, RWE generation and data harmonization.

A leader from digital health solutions firm CitiusTech suggests use of fast healthcare interoperability resources is useful in the face of evolving tech.

One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

A human challenge trial has been launched in the UK to investigate what happens when people who have already had COVID-19 are infected a second […]

A leader from the trial tech firm says COVID-19 has accelerated virtual studies, creating opportunities to improve patient engagement, costs and data.

The two companies have partnered to develop a systemic erythematosus assessment review to streamline clinical trials centered on the autoimmune disease.

Leaders from the supply chain solutions company share their thoughts on challenges associated with virtual and hybrid trials, and the COVID-19 pandemic.

The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.

Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.

A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, […]

The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues.

The free Patient-Centric Trial Development Toolkit is aimed toward helping sites and sponsors identify and minimize risks in rare-disease clinical studies.

Artificial intelligence software company Thirona has released PRAGMA-AI, technology that automates and accelerates CT scans in cystic fibrosis analysis.

The first in a series of reports released by Phesi and Accenture points toward the benefits of increased use of synthetic data in clinical research.

A couple of new developments to report in relation to Merck, known as MSD outside the US and Canada: the first being the rejection by […]

An expert speaking at the April 6 Clinical Development Innovations event will discuss an app that matches patients with clinical research opportunities.

A representative of the rare-disease specialist firm outlines the unique obstacles of orphan CNS disease research, and how professionals can overcome them.

The two companies will work together to evaluate the combination of SLC-391 and Keytruda in treating patients with advanced non-small cell lung cancer.

Two experts from CRO Phastar talk about how trial professionals face new, ever-changing challenges regarding collecting and disseminating patient data.

The company reports that its patient-centric virtual study technology currently is in use in more than 60 ongoing trials in over 40 different countries.

The companyâs Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.

The results of a recent Phase III study show caregivers can gauge by individual age, functional status to adapt treatment approaches to specific patients.

A leader from oncologist-founded trial tech specialists COTA shares how advanced data analysis can benefit cancer researchers and patients alike.